Web Industries Inc ., a precision converter and contract manufacturing organization (CMO), has allocated priority production capacity at its Holliston, MA, plant to support developers of COVID-19 lateral flow immunoassay (LFI) diagnostic tests. LFI tests are one type of diagnostic device under research and development as public health leaders seek solutions to efficiently test large numbers of people for COVID-19.

Web’s Lateral Flow Diagnostic Center of Excellence, a 6,500-sq-ft facility built specifically for LFI manufacturing, offers the following CMO services:

  • Automated reel-to-reel medical device production
  • In-house biochemistry lab
  • Reagent deposition
  • LFI strip manufacturing
  • Device assembly and packaging

The company's medical team has devised processes to help LFI device manufacturers expedite the transition from the research lab to large-volume reel-to-reel production of millions of tests. Web has an LFI economic and manufacturing model available to share with device developers, academic researchers, and companies responding to U.S. market needs for COVID-19 test kits.

“As the medical community mobilizes in response to ongoing COVID-19 outbreaks, rapid diagnostics will play an increasingly crucial role in slowing the spread of the disease,” says Kevin Young, Web Industries vice president of corporate development. “As an independent U.S. manufacturing partner, we’re ready to play our part in responding to the COVID-19 crisis.”

Web Industries’ U.S.-based manufacturing operations are a critical component of its overall value proposition. “Our LFI manufacturing plant is ready to work on a priority basis to be part of the solution,” Young says. “We can help LFI device developers to efficiently scale up production after they discover a viable LFI solution.”